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cu-1-Antitrypsin is found in hepatocytes as a high-mannose glycoprotein (Mr 49000), extracellularly as a 
complex-type glycoprotein (MI 54000). Deglycosylation of both forms with peptide: N-glycosidase led to 
proteins of identical app. M, (41000). The sequence of 26 N-terminal amino acids of rat cur-antitrypsin was 
determined. A high content of polar amino acids was found. The partially characterized presequence of 
in vitro synthesized cyr-antitrypsin showed a cluster of hydrophobic amino acids. A pre-peptide of 24 amino 
acids is proposed. There is no evidence for the existence of a propeptide. 
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1. INTRODUCTION 
a-1-Antitrypsin is the major plasma proteinase 
inhibitor in man and in a variety of animal species. 
It is a complex-type glycoprotein [1,2], which is 
synthesized in the liver [3] and secreted into the 
blood stream. Usually secretory glycoproteins are 
processed in both their carbohydrate moieties and 
their protein backbones. In [4] we described the ex- 
istence of two differently glycosylated forms of 
al-antitrypsin in rat hepatocytes. A high mannose 
glycoprotein of an app. M, 49000 was found to be 
the precursor of a complex-type glycoprotein of an 
app. M, 54000. To understand the processing of 
the protein part of ar-antitrypsin during its biosyn- 
thesis, in vitro translation studies have been carried 
out recently [5,6]. These studies suggested the ex- 
istence of a higher A4, precursor with an amino- 
terminal extension of about 20 amino acids. In 
order to characterize this prepeptide, we have com- 
pared the N-terminal amino acid sequence of 
cYr-antitrypsin purified from rat serum with the 
partially characterized N-terminal amino acid se- 
quences of ai-antitrypsin synthesized in rat 
hepatocyte primary cultures and in an in vitro 
translation system. 
2. MATERIALS AND METHODS 
+ To whom correspondence should be addressed 
L-[2,3-3H]Alanine (30-50 Ci/mmol), [4,5-‘HI- 
leucine (40-60 Ci/mmol), L-[35S]methionine 
(> 1000 Ci/mmol) were purchased from the Radio- 
chemical Centre (Amersham), protein A-Sepha- 
rose CL-4B, activated thiol-Sepharose 4B, and 
con A-Sepharose were obtained from Pharmacia 
(Freiburg), tunicamycin was from Calbiochem- 
Behring (Giessen). For the purification of @i-anti- 
trypsin rat serum was subjected to a 50% and a 
subsequent 80% ammonium sulfate precipitation, 
followed by affinity chromatography, first on acti- 
vated thiol-Sepharose 4B as in [7], second by 
affinity chromatography on con A-Sepharose as 
in [8], and third by preparative SDS-polyacryl- 
amide gel electrophoresis [9]. The polyacrylamide 
slice containing Lui-antitrypsin was cut from the 
gel, homogenized, mixed with Freund’s complete 
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adjuvant and used for the immunization of rabbits. 
Rat hepatocyte primary cultures were prepared as 
in [4,5]. Rat liver poly(A)+RNA was isolated from 
polysomes by phenol extraction as in [lo], followed 
by affinity chromatography on oligo(dT)-cellulose 
[ 11,121. Cell-free protein synthesis was carried out 
in a wheat germ system [ 131. Immunoprecipitation 
of cui-antitrypsin was done essentially as in [14]. 
SDS-polyacrylamide slab gel electrophoresis was 
carried out as in [9], fluorography as in [ 151. Alpha- 
1-antitrypsin synthesized in vitro or in vivo in the 
presence of [3H]leucine or [3H]alanine was precipi- 
tated with 2 mg of whale myoglobin and subjected 
to automatic Edman degradation with a Beckman 
Spinco Sequencer 890s following the method in 
[16]. The radioactivity of the thiazolinone deriva- 
tives of each degradation step was measured. In 
order to define the degradation step, an aliquot of 
each fraction was converted to the corresponding 
phenylthiohydantoin derivative and separated on a 
reversed phase column by isocratic high-pressure 
liquid chromatography [171. 
3. RESULTS AND DISCUSSION 
Fig.1 shows a fluorogram of a SDS-polyacryl- 
amide slab gel with radioactively labeled al-anti- 
trypsin, synthesized either in hepatocyte primary 
cultures or in a cell-free wheat germ system. Two 
different M, forms of cur-antitrypsin were found in 
hepatocytes and their medium. When glycosylation 
was inhibited by tunicamycin, only one M, form of 
cyi-antitrypsin (MI 41000) was obtained in hepato- 
cytes and their medium. To find out whether the 
high mannose type glycoprotein (M 49000) and 
the complex type (M, 54000) glycoprotein contain 
polypeptide chains of identical M, both forms of 
ai-antitrypsin were deglycosylated by peptide: N- 
glycosidase from almond emulsin. Enzymatic de- 
glycosylation led to polypeptides of identical 
electrophoretic mobility undistinguishable from 
that of unglycosylated cur-antitrypsin, synthesized 
in tunicamycin-treated hepatocytes (MI 41000). On 
the other hand, in vitro synthesized cur-antitrypsin 
exhibited an app. M, of 43000. 
To characterize the N-terminal extension of the 
in vitro synthesized al-antitrypsin, we have first 
determined the N-terminal amino acid sequence of 
mature cur-antitrypsin purified from rat serum. 
Fig.2 shows the first 26 amino acids. The high con- 
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Fig.1. Synthesis of a-1-antitrypsin in rat hepatocyte 
monolayers and in a cell-free system. (A) Rat hepatocyte 
monolayers were prepared as in [4,5]. About 3.9 x lo6 
cells of about 25 mg wet wt/dish were incubated in 
modified Waymouth medium [18] containing 25 ,Ki of 
[35S]methionine for 3 h at 37°C. Alpha-1-antitrypsin 
was immunoprecipitated from a 12000 x g supernatant 
of the cells (lane 1) after homogenization in 25 mM 
Tris-HCl buffer (pH 7.5), 20 mM NaCI, 1% deoxy- 
cholate (Na+) and 1% Triton X-100 and from the 
medium (lane 2). Alpha-1-antitrypsin immunopre- 
cipitated from cells (lane 4) and medium (lane 5) after 
incubation with 10 units of peptide: N-glycosidase from 
almonds [19,20] in a total volume of 0.1 ml of 10 mM 
acetate (Na+) (pH 5.1) and 0.1% sodium dodecyl sulfate 
at 37°C for 24 h. Alpha-1-antitrypsin immunopre- 
cipitated from hepatocytes treated with tunicamycin 
(3 rg/ml medium) for 1 h and labeled with 
[35S]methionine (25 ,Ki per dish) in the presence of 
tunicamycin (lane 3); (lane 6) same as lane 3, except hat 
al-antitrypsin was treated with 10 units of peptide: N- 
glycosidase; (lane 7) mixture of lanes 3 and 5; (B) 
Alpha-1-antitrypsin from tunicamycin-treated (3 pg/ml) 
hepatocytes (lane 1) and their medium (lane 2); al-anti- 
trypsin synthesized by in vitro translation of 
poly(A)+RNA in a wheat germ system (lane 3); mixture 
of lanes 2 and 3 (lane 4). The M, markers used were 
bovine serum albumin (68000), ovalbumin (43000), and 
alcohol dehydrogenase from yeast (37000). 
tent of polar amino acid residues is remarkable. 
The direct comparison with the sequence of human 
cui-antitrypsin shows homology only in 5 positions 
(1, 2, 4, 12 and 14). However, homology in 17 
amino acid residues is found when two insertions 
- one of 5 and one of 1 amino acid - are assumed 
in human cui-antitrypsin. 
N-Terminal amino acid sequences of rat al-anti- 
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Fig.2. N-terminal amino acid sequence of rat and human cu-1-antitrypsin. Rat al-antitrypsin was prepared and subjected 
to automatic Edman degradation as in section 2. The amino acid sequence of human ml-antitrypsin is taken from [21]. 
trypsin have been described in [6,22]. The 4 amino 
acids determined in [22] agree with our results. 
Arginine has been found in positions 6 and 8 [6]. 
In our studies threonine was identified at these 
positions. In contrast to our sequence data, as well 
as those in [6,22], Roll and Glew alanine was found 
[23] as the amino terminus of rat al-antitrypsin. 
When al-antitrypsin, synthesized in vitro in the 
presence of either [3H]leucine or [3H]alanine was 
subjected to radioactive Edman degradation, 
leucine was found in positions 8-l 1, 14, 17 and 22, 
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and alanine in positions 1, 12, 18, 23 and 26 (fig.3). 
In eukaryotic cells methionine is the first amino 
acid of all newly-synthesized proteins. However, 
from the fact that in our preparation alanine was 
found in the first Edman degradation cycle, it must 
be concluded that methionine had been removed 
from the amino terminus of the cul-antitrypsin 
precursor. Similar observations were made in [24] 
with preovomucoid synthesized in a reticulocyte 
lysate. Aminopeptidase activities likely to be 
responsible for the removal of the initiator 
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Fig.3. N-terminal sequence analysis of cY-1-antitrypsin translated in vitro. Alpha-1-antitrypsin was translated in a cell- 
free system derived from wheat germ in the presence of [3H]leucine (A) or [3H]alanine (B), and subjected to 30 Edman 
degradation cycles. 
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Fig.4. Comparison of the prepeptides of rat and human cu-1-antitrypsin. The partial amino acid sequence of rat 
cYi-antitrypsin is taken from fig.3. The amino acid sequence of the prepeptide of human cur-antitrypsin has been deduced 
from the nucleotide sequence of a cloned human cur-antitrypsin gene 1211. 
methionine residue, have been found in wheat 
germ and rabbit reticulocyte lysates [25]. 
If it is assumed that alanine at position 26 of the 
cur-antitrypsin, synthesized in vitro (fig.3B) cor- 
responds to the alanine at position 3 in the mature 
protein (fig.2), a prepeptide of 24 amino acids - 
including the N-terminal methionine - exists. A 
prepeptide of this length can be expected from the 
differences in app. A4, of in vitro synthesized and 
unglycosylated mature cur-antitrypsin (fig. 1). This 
assumption is further supported by the high se- 
quence homology with respect to alanine and 
leucine between the al-antitrypsin prepeptides of 
man and rat (fig.4). 
To study the possibility that the intracellular 
cYr-antitrypsin may exist as a proprotein as in the 
case of albumin, we have labeled cur-antitrypsin i  
hepatocyte primary cultures with [3H]leucine and 
subjected it to automatic Edman degradation. 
Radioactively-labeled leucine was found in posi- 
tion 24. Since leucine is also present at position 24 
of the mature al-antitrypsin purified from rat 
serum, we conclude that ar-antitrypsin does not ex- 
ist in a proprotein form in the cells. 
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